Table 2.
Summary of breast cancer therapies for all cases
| Invasive ductal carcinoma n = 611 (%) | Invasive lobular carcinoma n = 116 (%) | Total n = 727 (%) | |
|---|---|---|---|
| Mastectomy | 524 (85.8) | 94 (81.0) | 618 (85.0) |
| Breast conserving therapy | 61 (10.0) | 12 (10.4) | 73 (10.0) |
| Only biopsy, no surgical treatment | 26 (4.3) | 10 (8.6) | 36 (5.0) |
| Axillary surgery (clearance or sentinel node) | 461 (75.5) | 81 (69.9) | 542 (74.6) |
| Hormone therapy* | 134 (26.2**) | 31 (30.4**) | 165 (26.9**) |
| Trastuzumab | 0 | 0 | 0 |
| Chemotherapy | Unknown | Unknown | Unknown |
| Radiation | Unknown | Unknown | Unknown |
*
Estimated according to guidelines at diagnosis;
**
% of the hormone receptor-positive cases.